About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
The Global R&D Senior Study Forecasting Analyst is responsible for supporting and performing financial analyses and budgetary reconciliations of clinical trial budgets for a specific set (by indication) of ongoing and planned studies in a Therapeutic Area. The Senior analyst monitors study forecasts and is responsible for managing study expenses and forecasts for Plan, LBE, LRP and Portfolio submissions. This position collaboratively interfaces with the clinical teams and respective finance management and supports ad-hoc requests and projects.
Major Responsibilities
* The Senior Analyst will be responsible for a specific set of studies in the Oncology Therapeutic Area, supporting both ongoing and planned studies. List of responsibilities include:
* Support all aspects of the clinical trial budget process including trial cost analysis, scenario planning, contract funding approval, and study budget management through the study life-cycle
* Gathers data from a variety of sources and provides quality clinical study budget information and metrics to Clinical and Finance Management to aid in planning decisions
* Responsible for preparing predefined and ad hoc reports for the clinical teams and finance management, communicating on a timely basis for variance discrepancies and issue resolution.
* Support the business in assessing and investigating study spend vs. forecast.
* Demonstrated awareness and use of data sources and establishing regular cadence review of clinical studies (monthly LBEs, Quarterly R/OSS reviews, 50%/100% enrollment timepoints
* Interact with various levels of management and functions within the organization.
* Support finance management on ad-hoc requests and projects.
Qualifications
Requirements:
* BA/BS or equivalent related work experience is required. Degree in finance and/or health/life sciences preferred with a minimum of 4+ years of relevant experience.
* Strong financial, analytical and organizational skills
* Demonstrated ability to derive insights from data and distill into summarized format
* Strong attention to detail
* Execute priorities established by Manager with speed and agility.
* Ability to work with functional leaders across the business to monitor and review budgets and support business processes and information flows to functional groups
* Excellent time management with respect to priorities as well as self-management skills
* Proficient Excel skills required.
* Ability to work independently with flexibility to new or varied responsibilities
* Knowledge of finance systems and summarizing multiple data sources is a plus.
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.